Hasil Pencarian  ::  Simpan CSV :: Kembali

"Latar Belakang: Disfungsi mikrovaskular merupakan salah satu manifestasi cedera reperfusi letal. Ticagrelor diketahui memiliki efek kardioprotektif terhadap cedera reperfusi pada hewan coba. Efeknya pada manusia masih harus dibuktikan terutama terhadap perfusi mikrovaskular koroner. Tujuan: Mengetahui efek ticagrelor terhadap perfusi mikrovaskular koroner pada pasien infark miokard akut dengan elevasi segmen ST IMA-EST yang menjalani intervensi koroner perkutan primer IKPP. Metode: Penelitian ini merupakan studi eksperimental acak tersamar ganda yang dilakukan di Rumah Sakit Jantung dan Pembuluh Darah Harapan Kita pada bulan Agustus 2016 sampai November 2016. Pasien IMA-EST yang akan dilakukan IKPP dirandomisasi ke dalam dua kelompok yaitu kelompok yang mendapatkan ticagrelor dan yang mendapatkan clopidogrel sebelum IKPP. Dilakukan pemeriksaan myocardial blush kuantitatif dengan menggunakan program Quantitative Blush Evaluator QuBE. Hasil Penelitian: Terdapat total 40 subyek, 20 subyek kelompok ticagrelor dan 20 subyek kelompok clopidogrel. Tidak ditemukan perbedaan bermakna antara kelompok ticagrelor dengan clopidogrel terhadap nilai myocardial blush kuantitatif dengan QuBE 18,8 6,6-33,6 vs 18,1 12,4-32,3 , nilai p 0,978. Kesimpulan: Tidak terdapat perbedaan nilai myocardial blush kuantitatif pada pemberian ticagrelor sebelum IKPP pada pasien IMA-EST yang menjalani revaskularisasi bila dibandingkan dengan pemberian clopidogrel sebelum IKPP.

---

Background: Microvascular dysfunction become one of lethal reperfusion injury manifestation. Ticagrelor known having cardioprotective effect against reperfusion injury in animal trial. It effects in human need further investigation and evidence.

Objective: To determine the effect of ticagrelor on coronary microvascular perfusion in acute ST elevation myocardial infarction STEMI patients underwent primary percutaneous coronary intervention PPCI.

Method: This was a double blind randomized clinical trial conducted in National Cardiovascular Center Harapan Kita from August to November 2016. Acute ST elevation myocardial infarction patients underwent PPCI were randomized into two groups, ticagrelor or clopidogrel loading dose before PPCI. Quantitative myocardial blush score was assessed after PPCI using Quantitative Blush Evaluator QuBE program.

Result: There were 40 subjects included in this trial, 20 subjects in ticagrelor group and 20 subjects in clopidogrel group. There was no significant difference between two groups regarding the QuBE score 18,8 6,6 33,6 vs 18,1 12,4 32,3 , nilai p 0,978.

Conclusion: There is no difference on quantitative myocardial blush score in STEMI patient given ticagrelor before PPCI compare to clopidogrel. "

"Latar Belakang : Pasien infark miokard akut dengan elevasi segmen ST IMAEST yang mengalami revaskularisasi dengan intervensi koroner perkutan primer IKPP dapat terjadi cedera reperfusi yang mempengaruhi prognosis. Penelitianpada model hewan menunjukkan ticagrelor melindungi jantung dari cederareperfusi, namun demikian belum ada penelitian pada manusia yang menguji halini. Tujuan : Membandingkan pengaruh antara ticagrelor dengan clopidogrelterhadap cedera reperfusi yang diukur melalui kadar puncak high sensitivetroponin T hs-cTnT pada pasien IMA-EST yang mengalami revaskularisasi. Metode : Penelitian ini merupakan penelitian eksperimental acak tersamar gandayang dilakukan di Rumah Sakit Jantung dan Pembuluh Darah Harapan Kita padabulan Agustus 2016 sampai November 2016. Pasien IMA-EST yang akanmenjalani IKPP dirandomisasi ke dalam dua kelompok yaitu kelompok yangmendapatkan loading ticagrelor 180 mg dilanjutkan dosis rumatan 2x90 mg danyang mendapatkan loading clopidogrel 600 mg dilanjutkan dosis rumatan 1x75mg sebelum IKPP. Dilakukan pemeriksaan hs-cTnT 8 jam pasca dilatasi balonkateter pertama. Hasil Penelitian : Terdapat total 60 subyek, 30 subyek kelompok ticagrelor dan30 subyek kelompok clopidogrel. Tidak ditemukan perbedaan bermakna antaraticagrelor dengan clopidogrel terhadap kadar puncak hs-cTnT 9026 5026 ng/Lvs 9329 4664 ng/L, nilai p 0,809. Kesimpulan : Ticagrelor tidak menyebabkan kadar puncak high sensitivetroponin T yang lebih rendah bila dibandingkan dengan clopidogrel pada pasienIMA-EST yang mengalami revaskularisasi.

---

Background : Reperfusion injury influence prognosis in ST elevation myocardialinfarction STEMI patients after primary percutaneous coronary intervention PPCI . Previous study on animal models showed that ticagrelor may haveprotective effect on the heart by reducing reperfusion injury. However, no studyon humans has ever been done to confirm this.

Aim : To compare the effect of ticagrelor with clopidogrel on reperfusion injurycalculated by peak high sensitive troponin T hs cTnT in STEMI patients whounderwent revascularization.

Methods : This was a randomized controlled trial done in NationalCardiovascular Center Harapan Kita from August 2016 to November 2016.STEMI patients who underwent PPCI was randomized to either ticagrelor loadingdose 180 mg with maintenance of 2x90 mg or clopidogrel loading dose 600 mgwith maintenance of 1x75mg group. Peak hs Troponin T was measured 8 hoursafter first balloon dilatation.

Results : Sixty subjects was included in the study, 30 subjects in the ticagrelorgroup and 30 subjects in the clopidogrel group. There were no difference betweenticagrelor vs clopidogrel on peak hs cTnT levels 9026 5026 ng L vs 9329 4664 ng L, p value 0,809.

Conclusion : Ticagrelor does not cause a lower peak high sensitive troponin Tlevel compared to clopidogrel in STEMI patients who underwentrevascularization."

"Latar belakang: Remodeling jantung pasca Infark Miokard Akut (IMA-ST) dipercayasebagai penyebab masih tingginya angka komplikasi gagal jantung walaupun sudahdiberikan terapi standar dan tatalaksana revaskularisasi. Matriks ekstraseluler (EKM)memiliki peranan penting dalam proses remodeling. Nekrosis miokard menyebabkanpeningkatan kadar matriks metalloproteinase (MMPs) yang akan mendegradasi EKM.Berbagai studi eksperimental, menunjukkan bahwa inhibisi MMPs memberikan manfaatpada proses remodeling. Doksisiklin merupakan penghambat MMPs poten yang telahmemberikan efek menjanjikan terhadap remodeling pada hewan coba dan uji klinis tidaktersamar.Tujuan: Mengetahui efek doksisiklin terhadap struktur dan fungsi ventrikel sebagaipenanda remodeling pada IMA-ST yang telah menjalani IKPP.Metode: Penelitian ini menggunakan desain uji klinis acak tersamar ganda. Pasien IMASTdengan keterlibatan anterior atau Killip 2-3 dengan onset kurang dari 12 jam yangmenjalani IKPP terbagi secara acak pada grup Doksisiklin (2x100 mg tablet selama 7hari) sebagai terapi tambahan dari standar tatalaksana dan grup kontrol. Pemeriksaanekokardiografi dasar pada saat awal perawatan segera setelah IKPP. Ekokardiografievaluasi dilaksanakan pada bulan ke 4.Hasil: Terdapat 134 subjek yang masuk dalam penelitian ini. Setelah evaluasi lanjutan,terdapat 8 pasien drop out pada masing-masing grup karena meninggal dan lost to followup 58 subjek masuk dalam Grup Doksisiklin dan 60 subjek Grup Kontrol. Karakteristikdemografis dan klinis kedua grup homogen. Parameter ekokardiografi menunjukkanadanya peningkatan Left Ventricle End-Diastolic Volume Index (D LVEDVi) yang lebihrendah dibandingkan grup kontrol (9,2 (-21-45) mL/m2 vs 16 (-13-62) mL/m2,p=0,008). Selain itu, fungsi fraksi ejeksi (DLVEF) mengalami peningkatan pada grupDoksisiklin (2,36 ± 8,5 vs -2,6 ± 8,4; p 0,005). Persentase Adverse Remodeling lebihsedikit pada grup Doksisiklin. Rentang perbaikan Global Longitudinal Strain (DGLS)lebih besar pada grup Doksisiklin, walaupun statistik tidak bermakna. Angkarehospitalisasi tidak berbeda bermakna pada kedua grup.Kesimpulan: Doksisiklin memberikan efek perbaikan terhadap struktur dan fungsiventrikel kiri pada pasien IMA-ST yang telah menjalani IKPP

---

Background: Cardiac remodeling after acute myocardial infarction with ST elevation(STEMI) had been proved as the cause of the increased of heart failure complicationsdespite standard therapy and revascularization management. Extra cellular matrix (ECM)has an important role in the remodeling process. Myocardial necrosis causes increasedlevels of matrix metalloproteinase (MMPs) which will degrade ECM. Variousexperimental studies, showed that MMPs inhibition provides benefits in the remodelingprocess. Doxycycline is a potential MMPs inhibitor that has a promising effect onremodeling in experimental animals and clinical trials.Objective: To determine the effect of doxycycline on the structure and function ofventricles as a remodeling marker in STEMI that had undergone Primary PercutaneousCoronary Intervention (PPCI)Methods: We conducted a double-blind randomized control trial. Patients with STEMIanterior or with Killip class 2-3 with onset of less than 12 hours undergoing PPCI wererandomly assigned to the group that receiving Doxycycline (100 mg b.i.d for 7 days) asadjunctive therapy from standard management and the group without adjunct therapy. Aninitial echocardiographic examination was done after PPCI. Further evaluation was heldin 4 months after PPCI with an echocardiographic examination, which will be comparedbetween the initial examination and the evaluation.Results: There were 134 subjects included in this study. After further evaluation, therewere 8 patients drop out due to death and lost to follow up. Doxycycline group has 58and 60 subjects in Control group. Demographic and clinical characteristics of both groupsare homogeneous. Echocardiographic parameters showed change in Left Ventricle End-Diastolic Volume Index (D LVEDVi) significantly lower in Doxycycline group (9.2 (-21-45) mL/m2 vs. 16 (-13-62) mL/m2, p 0.008). In addition, the change of ejectionfraction (D LVEF) increased in the doxycycline group (2.36 ± 8.5 vs -2.6 ± 8.4, p0.005).The percentage of Adverse Remodeling is smaller in the Doxycycline group (70%vs 83%) and the range of D Global Longitudinal Strain (DGLS) is greater in Doxycyclinegroup, although both not statistically significant. Rehospitalization was not significantlydifferent between two groups.Conclusion: Doxycycline had effect in improving structure and function of the leftventricle in STEMI patients who have undergone PPCI"

"Intervensi Koroner Perkutan Primer (IKPP) merupakan pilihan utama untuk mengembalikan aliran darah dan perfusi pasien yang mengalami Infark Miokard Akut dengan Elevasi Segmen ST (IMA-EST). Tapi tidak selalu mengembalikan aliran yang cukup pada tingkat mikrosirkulasi, hal ini disebabkan oleh obstruksi mikrovaskular (OMV). Banyak penelitian telah membuktikan pengaruh inflamasi terhadap kejadian OMV, tingginya rasio neutrofil limfosit pasca IKPP menggambarkan respon inflamasi. Tujuan penelitian ini adalah untuk menilai hubungan rasio neutrofil limfosit (RNL) terhadap kejadian obstruksi mikrovaskular yang dinilai dengan pemeriksaan myocardial blush kuantitatif (QuBE). Metode: Sebanyak 33 subjek IMA–EST yang menjalani IKPP dipilih secara konsekutif sejak 1 September 2013 sampai 30 Oktober 2013. RNL diambil saat masuk UGD, penilaian myocardial blush (MB) diambil segera pasca IKPP, angiografi untuk RCA (RAO 30˚) dan LCA (LAO 60˚-90˚). Kemudian RNL dikirim ke laboratorium untuk diperiksa dengan dengan Sysmex 2000i, blush dinilai dengan program komputer QuBE. Perhitungan statistik dinilai dengan SPSS 17. Hasil: Dari 33 pasien didapatkan proporsi terbanyak berjenis kelamin laki-laki sebesar 75,7%, rerata usia pasien 56±9.8 tahun. Analisa statistik menunjukkan tidak terdapat hubungan antara RNL dan QuBE (β=-0,180;p=0,664) namun terdapat kecenderungan setiap kenaikan 1 unit RNL akan menurunkan QuBE sebesar 0,180 unit arbiter. Setelah dilakukan adjusted terhadap faktor perancu didapatkan kecenderungan penurunan yang lebih besar meskipun tetap tidak menunjukkan hubungan yang bermakna. (koef β=-0,331 ; p=0,527).

---

Primary percutaneus coronary intervention (PPCI) is a first of choice to return patient’s blood flow and perfusion with ST elevation myocardial infarction (STEMI). However, it is not always sufficiently reflow of microcirculation due to Microvascular Obstruction (MVO). Many studies had proved that neutrophil to lymphocyte ratio (NLR) has emerged as a potent composite inflammatory marker. The aim of this study is to evaluate association between NLR and MVO by Quantitative Blush Evaluator (QuBE).

Methode: 33 STEMI patients undergoing primary PCI were consecutivly recruited from September to October 2013. The NLR was withdraw at patient admission. We evaluate the myocardial blush immediately after PCI done. Angiography views were RAO 30˚ for RCA, and LAO 60˚-90˚for LCA. Then the NLR was sent to laboratory for examination. QuBE was done to evaluate myocardial blush. Statistical analysis was done by SPSS 17.

Results: From thirty three patients included in the study, there were 75,75% men, with mean age 56±9.8 years old. Statistical analysis showed no correlation between NLR and QuBE (β=-0,180;p=0,664) but there was decrease of 0,180 unit arbiter QuBE for each 1 unit of peripheral NLR. After adjustment of confounding factor, there was more decreasing value although there is no significant correlation. (coef β=-0,331;p=0,527)."

"ABSTRAKLatar Belakang: Perkembangan ilmu pengetahuan berhasil meningkatkan harapan hiduppasien yang mengalami infark miokardium. Namun pengobatan yang ada saat ini hanyamemperbaiki kondisi klinis pasien, tanpa adanya perbaikan otot jantung yang telah rusak.Hal inilah yang mendasari berkembangnya penelitian yang mempelajari tentang upayaregenerasi sel otot jantung dengan pemanfaatan sel punca yang salah satunya adalahMesenchymal Stem Cell MSC . Namun hasil yang didapatkan dari beberapa penelitianmenunjukkan hasil yang belum optimal. Hal ini disebabkan oleh beberapa faktordiantaranya adalah kadar dan fungsi dari sel punca yang tidak adekuat. Hingga saat inibelum ada penelitian yang mengevaluasi faktor-faktor yang mempengaruhi kadar MSCdalam Bone Marrow Mononuclear Cell BMMC pada pasien penyakit jantung iskemikkhususnya pengaruh fungsi sistolik ventrikel kiri.Tujuan: Menilai hubungan fungsi sistolik ventrikel kiri dengan kadar MSC dalam BMMCpada pasien penyakit jantung iskemik yang menjalani terapi sel punca Metode: Penelitian ini merupakan studi potong lintang dengan menggunakan datasekunder. Subjek penelitian adalah pasien penyakit jantung koroner dengan fungsi sistolikventrikel kiri

---

ABSTRACTBackground The development of science succeeded in increasing the life expectancy of patients with myocardial infarction. However, existing treatments only improve the clinical condition of the patient, without any improvement of the damaged heart muscle. Thus supposrt the development of research that studies to regenerate heart muscle cells with stem cells, for example Mesenchymal Stem Cell MSC . However, the results from several studies have shown modest results. It is caused by several factors including the levels and function of stem cells is inadequate. Until now, no study has evaluated the factors affecting the levels of MSC in Bone Marrow mononuclear cell BMMC in patients with ischemic heart disease in particular the influence of left ventricular systolic function.Objective To assess the association of left ventricular systolic function with MSC levels in BMMC in patients with ischemic heart disease who underwent stem cell therapyMethods This was a cross sectional study using secondary data. Subjects were patients with coronary heart disease with left ventricular systolic function "

"Latar belakang: FA pascaoperasi masih menjadi salah satu komplikasi yang sering terjadi pada pasien pascaoperasi BPAK. FA pascaoperasi BPAK memiliki implikasi klinis dan ekonomis yang besar. Pencegahan FA pascaoperasi bisa diberikan secara medikamentosa, tetapi perlu dipilih pasien yang memang memiliki risiko tinggi untuk kejadian tersebut. Tujuan: Mengetahui kemampuan prediksi kombinasi skor CHA2DS2-VASc dan parameter ekokardiografi terhadap kejadian FA pascaoperasi BPAK. Mengetahui apakah dapat dibentuk suatu sistem skor yang baru untuk memprediksi FA pascaoperasi BPAK berdasarkan karakteristik subjek penelitian dan bagaimana kemampuannya. Metode: Semua pasien yang menjalani BPAK tanpa kombinasi operasi lainnya pada bulan Juli-Desember 2017 akan menjadi subjek penelitian. Selanjutnya, akan dilakukan pengumpulan data dari rekam medis pasien mengenai karakteristik dasar, parameter ekokardiografi preoperasi, tindakan operasi, serta skor CHA 2DS2-VASc pasien. Model prediksi yang didapat kemudian dianalisa lebih lanjut untuk mendapatkan suatu sistem skor untuk memprediksi kejadian FA pascaoperasi BPAK. Hasil: Terdapat 335 subjek penelitian yang masuk dalam kriteria penelitian ini. Angka kejadian FA pascaoperasi BPAK pada penelitian ini adalah 20 . Kombinasi skor CHA 2DS2-VASc dan parameter ekokardiografi memiliki kemampuan prediksi yang baik terhadap kejadian FA pascaoperasi BPAK dengan sensitivitas 83,8 dan spesifisitas 74,2 AUC 0,868; IK 95 0,821-0,915 . Selanjutnya, skor baru yang dibentuk dari model prediksi berdasarkan karakteristik subjek penelitian ini juga memiliki kemampuan prediksi kejadian FA pascaoperasi BPAK yang seimbang dengan kombinasi skor CHA2DS2-VASc dan parameter ekokardiografi sensitivitas 79,4 , spesifisitas 81,3 , AUC 0,885, IK 95 0,84-0,931 Kesimpulan: Kombinasi skor CHA2DS2-VASc dan parameter ekokardiografi memiliki kemampuan yang baik untuk memprediksi kejadian FA pascaoperasi. Sistem skor baru yang dibentuk memiliki kemampuan prediksi yang sebanding dengan kombinasi skor CHA 2DS2-VASc dan parameter ekokardiografi terhadap kejadian FA pascaoperasi BPAK.

---

Background Postoperative atrial fibrillation is still a major complication in post coronary artery bypass graft CABG patients. It has huge clinical and economical implications. Prevention of postoperative atrial fibrillation could be done by giving the right medications. However, the prevention strategy should be given only to high risk patients. Therefore, there is a need a tool to identify which patients have a higher risk for postoperative atrial fibrillation so that they should be given the right prevention strategy. Objectives To investigate the ability of combination of CHA2DS2 VASc score and echocardiography parameters to predict post CABG atrial fibrillation. To investigate whether there is a new scoring system to predict the incidence of post CABG patients. Methods All patients who underwent CABG operation without any other concommitant cardiac surgery in July December 2017 were included in this study. Furthermore, data collection from the patiens rsquo medical record will be performed on basic characteristics, preoperative echocardiography parameters, and patients rsquo CHA2DS2 VASc score. The prediction model obtained is then further analyzed to construct a new scoring system to predict the post CABG atrial fibrillation incidence. Results There were 335 patients included in this study. The incidence of post CABG atrial fibrillation was 20 . Combination of CHA2DS2 VASc score and echocardiographic parameters have good predictive ability on post CABG atrial fibrillation with 83,8 sensitivity and 74,2 specificity AUC 0,868, 95 CI 0,821 0,915 . Furthermore, new score formed from the predictive model based on the characteristics of the study subjects had comparable predictive ability with the score based on combination of CHA2DS2 VASc and echocardiography parameters. Conclusion Combination of CHA2DS2 VASc score and echocardiographic parameters have a good ability to predic post CABG atrial fibrillation incidence. The newly established scoring system has predictive capabilities for post CABG atrial fibrillation incidence comparable to the score based on combination of CHA2DS2 VASc score and echocardiography parameters. "

"Sindrom koroner akut (SKA) merupakan salah satu kegawatan kardiovaskular diInstalasi Gawat Darurat (IGD). Tatalaksana SKA yang ada saat ini membutuhkan waktuminimal 3 jam untuk menentukan apakah pasien dirawat atau dipulangkan, hal ini akanberdampak pada kepadatan IGD dan pemborosan biaya perawatan. European Society ofCardiology merekomendasikan algoritma 0/1 jam pada pasien dengan gambaran EKGnon elevasi segmen ST (NEST) dengan menggunakan high sensitive troponin T (hscTnT)dalam menegakkan atau penapisan infark miokard akut non elevasi segmen ST(IMA-NEST). Penelitian ini bertujuan untuk membandingkan nilai diagnostik hs-cTnTjam ke-1 dan jam ke-3 pada terduga SKA non elevasi segmen ST dengan awitan nyeridada kurang dari 6 jam. Desain penelitian potong lintang. Sebanyak 100 subjekpenelitian yang diambil secara konsekutif sampling. Sensitivitas, spesifisitas, nilaiprediksi positif, dan nilai prediksi negatif kadar hs-cTnT 0/1 jam secara berurutanadalah 93,75%, 98,81%, 93,75%, 98,81%, sementara sensitivitas, spesifisitas, nilaiprediksi positif, dan nilai prediksi negatif kadar hs-cTnT 0/3 jam secara berurutanadalah 87,50%, 96,81%, 93,33% 97,65%. Pemeriksaan hs-cTnT 0/1 jam dapatdipergunakan dalam rule in dan rule out terduga IMA-NEST dengan awitan nyeri dadakurang dari 6 jam.

---

Acute coronary syndrome (ACS) is one of the cardiovascular events in an EmergencyInstallation (ED). The patients management of ACS required at least 3 hours todetermined whether the patient hospitalized or outpatient, these would increased EDscrowded and high cost treatment. The European Society of Cardiology recommended a0/1 hour algorithm in patients with ECG showed non ST segment elevationusing highsensitive troponin T (hs-cTnT) parameter to rule in or rule out non ST segmentelevation myocard infarct (NSTEMI).We aimed to compare diagnostic values of hscTnTat the 1st and 3rd hour in NSTEMI with chest pain onset less than 6 hours. Studydesign was cross sectional. A total of 100 subjects enrolled by consecutive samplingmethod. Sensitivity, specificity, positive predictive value, and negative predictive valueof hs-cTnT 0/1 hours were 93.75%, 98.81%, 93.75%, 98.81%, while sensitivity,specificity, positive predictive value, and the negative predictive value of hs-cTnT 0/3hours were 87.50%, 96.81%, 93.33%, 97.65%. Hs-cTnT 0/1 hour test can be used inrule in and rule out suspect NSTEMI with the chest pain onset less than 6 hours."

"Latar Belakang : Rasio netrofil-limfosit (NLR) sudah banyak diteliti memiliki hubungan yang erat dengan luaran penyakit kardiovaskular. Hal ini berhubungan dengan proses inflamasi yang dapat menyebabkan perubahan struktural dan fungsi dari jantung yang dapat dinilai dengan salah satunya fraksi ejeksi (EF). Pasien IMA-EST yang mendapatkan IKPP memiliki resiko untuk mengalami perubahan EF yang berhubungan dengan NLR saat admisi.Tujuan : Mengetahui hubungan antara NLR rendah dengan peningkatan fraksi ejeksi (EF) ventrikel kiri pada pasien IMA-EST yang mendapatkan IKPP.Metode : Desain penelitian ini adalah kohort retrospektif dan data dilaporkan dalam bentuk deskriptif dan analitik korelasi. Dilakukan analisa hubungan NLR admisi pasien STEMI yang mendapatkan IKPP dengan EF ≤50% yang di ambil dengan ekokardiografi selama perawatan, akan kemudian dilakukan ekokardiografi kembali pada bulan ke-3.Hasil : Total sampel penelitian adalah 58 subjek dengan 91,4% merupakan laki-laki. Rerata nilai EF I 42% dan EF ke-2 45,9%. Pasien dibagi menjadi 2 kelompok dengan NLR <7 dan >7. Terdapat perbedaan proporsi antara kedua kelompok yang ditunjukan dengan nilai p sebesar 0,05. Subjek yang mempunyai kadar NLR >7 lebih beresiko sebesar 4,30x untuk tidak mengalami perbaikan. Faktor yang paling dominan yang mempengaruhi perbaikan EF pada penelitian ini adalah NLR <7 dengan OR sebesar 6,56 (1,31-32,84) setelah dikontrol oleh variable lekosit dan multivesel diseases.Kesimpulan : Terdapat hubungan antara NLR dengan perbaikan EF ventrikel kiri pada Pasien IMA-EST yang mendapatkan IKPP

---

Background : The neutrophil-lymphocyte ratio (NLR) has been widely studied to have a close relationship with cardiovascular disease outcomes. This is related to the inflammatory process that can cause structural and functional changes of the heart which can be assessed by ejection fraction (EF). STEMI patients who receive Primary PCI are at risk for experiencing changes in EF related to NLR at admission.

Objective: To determine the relationship between low NLR and increased left ventricular ejection fraction (EF) in STEMI patients who receive primary PCI.

Methods: The design of this study was a retrospective cohort and the data were reported in descriptive and analytic form. An analysis of the relationship between NLR admissions for STEMI patients who received primary PCI with an EF 50% or below were carried out by echocardiography during treatment, then echocardiography was performed again in the 3rd month.

Results: The total sample of the study ware 58 subjects with 91.4% of males. The mean score for EF I was 42% and EF 2 was 45.9%. Patients were divided into 2 groups with NLR <7 and >7. There is a difference in the proportion between the two groups as indicated by a p-value of 0.05. Subjects who have NLR levels > 7 are 4,30x more at risk for not experiencing improvement. The most dominant factor influencing the improvement of EF in this study was NLR <7 with an OR of 6.56 (1.31-32.84) after being controlled by leukocyte and multivesel diseases variables.

Conclusion: There is a relationship between NLR and left ventricular EF improvement in IMA-EST patients who received PCI"

"[ABSTRAKLatar Belakang. Perburukan fungsi ginjal berkaitan dengan luaran klinis yang lebih buruk pada pasien gagal jantung dekompensasi akut. Karakteristik klinis pada saat pasien masuk ke unit gawat darurat (UGD) dapat menolong untuk identifikasi pasien yang berisiko terhadap kejadian perburukan fungsi ginjal. Tujuan penelitian ini adalah membuat sistem skor untuk mempermudah identifikasi pasien yang berisiko terhadap perburukan fungsi ginjal pada gagal jantung dekompensasi akut.Metode. Studi kohort retrospektif dilakukan terhadap 614 pasien yang menjalani perawatan karenan gagal jantung dekompensasi akut. Perburukan fungsi ginjal didefinisikan sebagai peningkatan nilai kreatinin serum ≥ 0.3 mg/dL kapanpun selama perawatan atau ≥ 25% dari awal masuk perawatan.Hasil. Perburukan fungsi ginjal terjadi pada hampir 26% pasien. Prediktor independen terhadap kejadian perburukan fungsi ginjal yang didapat melalui analisis dengan logistik regresi backward selection adalah usia > 75 tahun (p < 0.0001); perempuan (p = 0.034); riwayat hipertensi (p = 0.001); anemia (p = 0.005); dan serum Creatinin saat masuk di UGD > 2.5 mg/dL (p = 0.013). Sistem skor dibuat dari model akhir tersebut. Dilakukan validasi internal dengan metode bootstrap didapatkan hasil optimisme yang baik (0.01088808).Kesimpulan. Sistem skor baru dapat memprediksi kejadian perburukan fungsi ginjal pada pasien gagal jantung dekompensasi akut yang menjalani rawat inap.

---

ABSTRACTBackground. Worsening renal function (WRF) is associated with worse outcomes among patients who are hospitalized with acute decompensated heart failure (ADHF). Clinical characteristics at admission may help identify patients at increased risk of WRF. The aim of this study was to create in admission scoring system to simplify identification patients at risk of WRF in ADHF setting.Methods. A retrospective data of 614 patients admitted with ADHF was analyzed. By the definition WRF occurred when serum Creatinin increased at anytime during hospitalization by ≥ 0.3 mg/dL or by ≥ 25% from admission.Results. Worsening renal function developed in near 26% patients. The independent predictors of WRF analyzed with backward selection logistic regression were: age > 75 years old (p < 0.0001), female (p = 0.034); history of hypertension (p = 0.001); anemia (p = 0.005); and in admission serum Creatinin (p = 0.013). A scoring system was generated from this final model. An internal validation with bootstrap method showed good optimism (0.01088808).Conclusion. A new scoring system could predict in-hospital worsening renal function among patients hospitalized with acute decompensated heart failure., Background. Worsening renal function (WRF) is associated with worse outcomesamong patients who are hospitalized with acute decompensated heart failure(ADHF). Clinical characteristics at admission may help identify patients at incresedrisk of WRF. The aim of this study was to create in admission scoring system tosimplify identification patients at risk of WRF in ADHF setting.Methods. A retrospective data of 614 patients admitted with ADHF was analyzed.By the definition WRF occurred when serum Creatinin increased at anytime duringhospitalization by ≥ 0.3 mg/dL or by ≥ 25% from admission.Results. Worsening renal function developed in near 26% patients. Theindependent predictors of WRF analyzed with backward selection logisticregression were: age > 75 years old (p < 0.0001), female (p = 0.034); history ofhypertension (p = 0.001); anemia (p = 0.005); and in admission serum Creatinin (p= 0.013). A scoring system was generated from this final model. An internalvalidation with bootstrap method showed good optimism (0.01088808).Conclusion. A new scoring system could predict in-hospital worsening renal function among patients hospitalized with acute decompensated heart failure.]"

"[Latar belakang : Fibrilasi atrium merupakan aritmia yang paling sering terjadipasca bedah pintas arteri koroner. Peningkatan stress oksidatif, inflamasi, aktivitasneurohormonal memiliki peran terhadap kejadian fibrilasi atrium pasca bedahpintas arteri koroner. Berbagai strategi farmakologis seperti antiaritmia,antiinflamasi, dan antioksidan sudah dipelajari untuk menurun risiko kejadianfibrilasi atrium pasca bedah pintas arteri koroner namun kejadian fibrilasi atriummasih tinggi. Allopurinol memiliki efek antioksidan, namun belum ada uji klinisyang mempelajari efek allopurinol terhadap kejadian fibrilasi atrium. Penelitianini bertujuan untuk menilai efek allopurinol terhadap kejadian fibrilasi atriumpasca bedah pintas arteri koronerMetode : Uji klinis randomisasi tersamar ganda dilakukan di Rumah SakitPembuluh Darah Harapan Kita (RSJPDHK) pada periode April ? Mei 2015.Pasien BPAK on-pump elektif yang diseleksi secara consecutive samplingkemudian dibagi menjadi dua kelompok yaitu kelompok allopurinol dankelompok plasebo dengan randomisasi blok. Subyek diberikan allopurinol 600 mg/ plasebo dosis tunggal sejak 1 hari sebelum operasi sampai hari ke-5 pascaoperasi. Dilakukan pengamatan kejadian fibrilasi atrium pasca operasi sampaipasien pulang dari perawatan.Hasil : Sebanyak 90 subyek diikutsertakan dalam penelitian, 45 subyek padamasing-masing kelompok. Kejadiaan fibrilasi atrium lebih rendah secarabermakna pada kelompok allopurinol (12 (26,7%) vs 22 (48,9%) p 0,030). Kesimpulan : Pemberian allopurinol perioperatif menurunkan kejadian fibrilasi atrium pasca bedah pintas arteri koroner.;Background : Atrial fibrillation is the most common arrhythmias after coronaryartery bypass surgery. Increased oxidative stress, inflammation, neurohormonalactivity has a role on the incidence of atrial fibrillation after coronary arterybypass surgery. Various pharmacological strategies such as antiarrhythmias, antiinflammatory,and antioxidant have been studied to decrease atrial fibrillationincident after coronary artery bypass surgery, but the incidence of atrialfibrillation is still high. Allopurinol has antioxidant effects, but there was noclinical trials that studied the effect of allopurinol on atrial fibrillation incidence.The aim of this study to assess allopurinol effect on the atrial fibrillation incidenceafter coronary artery bypass surgery. Methods: A double-blind randomized clinical trial conducted at the NationalCardiovascular Center Harapan Kita in Jakarta from April to May 2015. Electiveon-pump CABG patients were selected by consecutive sampling then divided intotwo groups: allopurinol and placebo groups with block randomization. Subjectsgiven allopurinol 600 mg / placebo single dose since 1 day before surgery untilthe 5th day post-surgery. The incidence of atrial fibrillation was observedpostoperatively.Results: A total of 90 subjects were included in the study, 45 subjects in eachgroup. Occurrence of atrial fibrillation was significantly lower in the allopurinolgroup (12 (26.7%) vs 22 (48.9%) p 0,030). Conclusion: Perioperative allopurinol reduced the incidence of atrial fibrillation after coronary artery bypass surgery., Background : Atrial fibrillation is the most common arrhythmias after coronaryartery bypass surgery. Increased oxidative stress, inflammation, neurohormonalactivity has a role on the incidence of atrial fibrillation after coronary arterybypass surgery. Various pharmacological strategies such as antiarrhythmias, antiinflammatory,and antioxidant have been studied to decrease atrial fibrillationincident after coronary artery bypass surgery, but the incidence of atrialfibrillation is still high. Allopurinol has antioxidant effects, but there was noclinical trials that studied the effect of allopurinol on atrial fibrillation incidence.The aim of this study to assess allopurinol effect on the atrial fibrillation incidenceafter coronary artery bypass surgery. Methods: A double-blind randomized clinical trial conducted at the NationalCardiovascular Center Harapan Kita in Jakarta from April to May 2015. Electiveon-pump CABG patients were selected by consecutive sampling then divided intotwo groups: allopurinol and placebo groups with block randomization. Subjectsgiven allopurinol 600 mg / placebo single dose since 1 day before surgery untilthe 5th day post-surgery. The incidence of atrial fibrillation was observedpostoperatively.Results: A total of 90 subjects were included in the study, 45 subjects in eachgroup. Occurrence of atrial fibrillation was significantly lower in the allopurinolgroup (12 (26.7%) vs 22 (48.9%) p 0,030). Conclusion: Perioperative allopurinol reduced the incidence of atrial fibrillation after coronary artery bypass surgery.]"